PRO HRT Monitoring Panel
Blood Count and Hormone Monitoring for Testosterone and Hormone Replacement Therapy
PRO Sports Medicine Learning Center
Introduction
Hormone therapy is one of the most monitoring-dependent treatments in medicine. Testosterone replacement therapy (TRT) and other forms of hormone replacement therapy (HRT) can meaningfully improve how people feel and function, but they also change physiology in ways that need to be watched, especially red blood cell production, estrogen balance, prostate markers in men, and progesterone balance in women.
The PRO HRT Monitoring Panel is designed for that job. It reports 16 biomarkers for men or women: a complete blood count, a core hormone profile, and one sex-specific marker. It is used to establish a baseline before therapy and to monitor response and safety during treatment.
What the Panel Measures
Complete blood count (CBC), 10 markers: hematocrit, hemoglobin, red blood cell count, white blood cell count, platelet count, MCV, MCH, MCHC, RDW, and MPV. The panel includes a CBC without a white-cell differential.
Hormone and endocrine health, 5 shared markers: total testosterone, free testosterone (calculated), SHBG, albumin, and estradiol.
Sex-specific marker, 1: prostate-specific antigen (PSA) in the male configuration, or progesterone in the female configuration.
Why the Blood Count Comes First
Testosterone stimulates the kidneys to release erythropoietin and increases iron availability for red blood cell production. The result is that hemoglobin and hematocrit often rise during TRT. A modest rise can be expected. A large rise, called erythrocytosis, thickens the blood and is the most common laboratory reason to adjust testosterone therapy.
Hematocrit (HCT) is the percentage of blood volume made up of red cells. It is the single most watched safety marker in TRT. Clinical guidelines generally advise caution before starting testosterone when hematocrit is already elevated, and recommend reassessing therapy when hematocrit rises above about 54%. Dehydration, sleep apnea, smoking, and living at altitude can also raise hematocrit.
Hemoglobin (HGB) is the oxygen-carrying protein in red cells and tracks closely with hematocrit.
Red blood cell count (RBC) is the number of red cells per volume of blood.
MCV, MCH, and MCHC describe the average size of red cells and how much hemoglobin they contain. Small, pale cells can suggest iron deficiency; large cells can suggest low B12 or folate, alcohol use, or certain medications. Frequent blood donation to manage hematocrit can lower iron stores, which shows up here.
RDW (red cell distribution width) measures variation in red cell size. A high RDW can be an early sign of a developing nutrient deficiency.
White blood cell count (WBC) reflects immune cells. Infection, stress, steroids, and intense exercise can raise it; some conditions and medications lower it.
Platelet count (PLT) and MPV (mean platelet volume) describe the cells that help blood clot. Abnormal values may be followed up with repeat testing.
The Hormone Profile
Total testosterone measures all testosterone in the blood. Before therapy, morning testing is standard because testosterone peaks early in the day; low results are usually confirmed on a second morning test. During therapy, the timing of the sample relative to your dose matters a great deal. An injection taken the day before will read very differently from one taken a week before. Your provider will tell you when to collect.
SHBG binds testosterone tightly and determines how much is available to tissues. Low SHBG is common with insulin resistance and excess body fat; high SHBG is common with aging, low body fat, and thyroid excess. SHBG can change during therapy and with weight loss.
Albumin binds testosterone loosely and, together with SHBG, is used to calculate free testosterone. It also reflects liver function and nutrition.
Free testosterone (calculated) estimates the unbound fraction available to tissues. When SHBG is unusually high or low, free testosterone often tells a more accurate story than total testosterone.
Estradiol is the main estrogen. In men, a portion of testosterone is converted to estradiol by the aromatase enzyme, mostly in fat tissue. Estradiol in men supports bone density, libido, and vascular health, so the goal is balance, not suppression. Estradiol often rises during TRT, particularly in men with more body fat. In women, estradiol reflects ovarian function or hormone therapy and varies through the cycle.
Prostate-Specific Antigen (PSA)
PSA is a protein made by the prostate. It can rise with prostate enlargement, inflammation, infection, recent ejaculation, vigorous cycling, and prostate cancer. Testosterone therapy can produce a modest PSA increase, especially in the first months.
Guidelines generally recommend a baseline PSA in men considering TRT, at ages where screening is appropriate, with follow-up during treatment. A rise over time, rather than a single number, is what usually prompts further evaluation. PSA interpretation depends on age, family history, medications, and prior results, and it is always reviewed with a provider.
Progesterone (Female Configuration)
What it measures: progesterone is a steroid hormone produced mainly by the ovaries after ovulation, by the corpus luteum that forms from the released egg. Smaller amounts come from the adrenal glands. The test measures the level circulating in the blood at the moment of collection.
What it does: progesterone prepares and stabilizes the lining of the uterus in the second half of the menstrual cycle, and it counterbalances estrogen's growth-promoting effect on that lining. It also acts on the brain, where its metabolites have calming effects and can influence sleep, and it plays roles in breast tissue, body temperature, and fluid balance.
Why it matters for women on HRT: in menopausal hormone therapy, a woman who still has her uterus is generally prescribed a progestogen, either progesterone or a related synthetic progestin, alongside estrogen, because estrogen alone can overstimulate the uterine lining. A progesterone level can help a provider confirm that prescribed progesterone is being absorbed, understand symptoms such as sleep changes, mood shifts, or breakthrough bleeding, and see the balance between estradiol and progesterone in context. Two cautions apply. Blood levels vary widely with the route used (oral capsules, vaginal products, and creams behave very differently), and synthetic progestins are not detected by a progesterone test at all. Your provider interprets the number with your specific product, dose, and timing in mind.
Cycle timing: in women who still have menstrual cycles, progesterone is low in the first half of the cycle and rises after ovulation, peaking roughly seven days before the next period. A mid-luteal sample, often around day 21 of a 28-day cycle, is the classic way to judge whether ovulation has occurred; a sample taken early in the cycle will be low by design. If your cycles are irregular, your provider may adjust the timing or repeat the test. In perimenopause, ovulation becomes less regular, so progesterone can vary considerably from cycle to cycle. Women taking hormonal contraception typically have low progesterone because ovulation is suppressed.
General context: a single progesterone value is a snapshot, not a diagnosis. It is interpreted alongside estradiol, cycle day or menopausal status, symptoms, and the treatment plan, and unexpected results are often repeated before anything changes. In the female configuration of this panel, estradiol and progesterone together give your provider a view of both sides of the hormone balance that HRT is designed to manage.
Who the Panel Is For
Men starting or using testosterone replacement therapy
Women using hormone replacement therapy
Patients on other medically supervised hormone optimization programs
Anyone who needs to track hematocrit and hormone levels over time
How to Prepare
Follow the kit instructions and your provider's timing guidance.
Before therapy: collect in the morning, ideally before 10 a.m.
During therapy: collect at the point in your dosing cycle your provider specifies, often at the trough just before a dose or at a set midpoint. Write down the date and time of your last dose.
Hydrate well the day before. Dehydration can falsely raise hematocrit.
Men: avoid ejaculation and long bike rides for about 48 hours before collection, which can temporarily raise PSA.
Women: if you still have menstrual cycles, ask your provider which cycle day to collect, since progesterone is most informative about seven days before your expected period. If you use progesterone therapy, note the product, route, dose, and time of your last dose. Write down the first day of your last period.
Pause high-dose biotin if your provider agrees, because it can interfere with some hormone immunoassays.
How Your Results Are Reviewed
A PRO Sports Medicine provider reviews your results with your dose, timing, symptoms, and history. Common discussion points include whether testosterone and free testosterone are in the intended range for your protocol, whether hematocrit needs attention, whether estradiol is balanced, whether PSA is stable in men, and whether progesterone fits the treatment plan and cycle timing in women. Changes to therapy are made only by your provider. Clinical review is included for active PRO Foundations members.
How It Fits PRO Care
Hormone therapy at PRO is never managed by symptoms alone. The HRT Monitoring Panel supplies the baseline and safety data that make individualized dosing possible. Patients who also want metabolic, cardiovascular, thyroid, and nutrient data can step up to the PRO Performance + HRT Monitoring Panel, and patients also using GLP-1 care can choose the PRO GLP + HRT Monitoring Panel. Hormones also interact with body composition and sleep; see Body Composition & Sarcopenia and Sleep, Recovery & Circadian Health.
Order the PRO HRT Monitoring Panel
Important Information
This article is educational and is not medical advice. HRT Monitoring Panel results support clinical assessment and monitoring and do not establish treatment safety or effectiveness on their own. Do not change any hormone dose based on a lab result without speaking to your provider. All results are reviewed by a licensed PRO Sports Medicine provider.
Key References
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018.
U.S. Food and Drug Administration. Safety Communication: Biotin (Vitamin B7) May Interfere With Lab Tests. 2017, updated 2019.
Clinical Perspective
The two numbers that most often change a hormone plan are hematocrit and the timing-adjusted testosterone level. Both can be misread without context: dehydration inflates hematocrit, and sampling at the wrong point in a dosing cycle can make a well-dosed patient look over- or under-treated. Consistent timing, good hydration, and comparison with prior results turn the HRT Monitoring Panel into a reliable tool for safe, individualized therapy.